Bruker is proud to partner with Dr. Harald Schwalbe of the Goethe University in Frankfurt on using NMR to combat COVID-19.
Through an initiative based out of the Goethe University in Frankfurt Germany, an international consortium of 30 RNA research groups has been formed to research the SARS-CoV-2 virus. Using NMR spectroscopy, all proteins relevant to the SARS-CoV-2 virus are being structurally investigated and RNA elements are forming potential targets for new drugs. Below is an interview conducted with Dr. Schwalbe and Dr. Falko Busse of Bruker BioSpin on how NMR is being used to research COVID-19 and what the future will hold for Bruker and for society.
Also, please be sure to register for a webinar featuring the team from GU Frankfurt happening on July 21st.